Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Rea, 2005
Cohort:
Cardiovascular Health Cognition Study/Cardiovascular Health Study Cognition Study
Risk Factor:
Statin use
Exposure Detail
The interviewers ascertained exposure information via an annual medication inventory. The investigators reported results separately for ever/never statin use, lipophilic statin use, less lipohilic statin use, current/past/never use, and duration of use. This entry pertains to results on duration of statin use.
The investigators compared incident AD risk in three separate sets of comparison groups: the group of participants who used statins for less than a year ("< 1 year") and the reference group of participants who did not use statins or non-statin LLAs ("Never used"); the group of participants who used statins between one to three years ("1-3 years") and the reference group of participants who did not use statins or non-statin LLAs ("Never used"); and the group of participants who used statins for more than three years ("> 3 years") and the reference group of participants who did not use statins or non-statin LLAs ("Never used"). The article does not provide the exposure distribution for the study cohort in regards to duration of statin use.
Ethnicity Detail
Caucasian participants contributed 91% of person-time.
Age Detail
Cohort members older than eighty years of age contributed 54% of person-time. The article does not provide the average age for members of this cohort.
Screening and Diagnosis Detail
Screening Method:
Brain Imaging
MMSE
Mini-Mental State Examination (Folstein 1975)
Other
Covariates & Analysis Detail
Analysis Type:
Cox proportional hazards regression
AD Covariates:
A
age
E
education
G
gender
MMSE
baseline MMSE
BSTR
baseline stroke
BCHD
basline CHD
TD Covariates:
A
age
E
education
G
gender
MMSE
baseline MMSE
BSTR
baseline stroke
BCHD
basline CHD